PT MITSUBISHI TANABE PHARMA

Company Type: PT Mitsubishi Tanabe Pharma Indonesia operates as a pharmaceutical company that encompasses both manufacturing and trading activities within Indonesia. While it primarily focuses on the sales, marketing, and distribution of pharmaceutical products, it is also involved in local production or contract manufacturing to serve the Indonesian market.

Company Introduction:

PT Mitsubishi Tanabe Pharma Indonesia is a subsidiary of Mitsubishi Tanabe Pharma Corporation, a leading research-driven pharmaceutical company headquartered in Japan. Established to serve the Indonesian market, the company is dedicated to improving human health by providing innovative and high-quality pharmaceutical products. It leverages the parent company's global expertise and product portfolio to address various medical needs in Indonesia.

Key Activities:

1. Manufacturing and Production: Engages in the local production or contract manufacturing of pharmaceutical products to meet the specific needs and regulatory requirements of the Indonesian market, ensuring local availability and compliance.

2. Sales and Marketing: Promotes and sells a wide range of prescription and over-the-counter medications to healthcare professionals, hospitals, and pharmacies across Indonesia.

3. Distribution: Manages the supply chain and distribution network to ensure timely and efficient delivery of its pharmaceutical products throughout the country, maintaining product integrity and quality.

4. Research and Development Support: Contributes to the global R&D efforts of Mitsubishi Tanabe Pharma Corporation by conducting clinical trials and other related activities in Indonesia, facilitating the introduction of new therapies.

5. Regulatory Affairs: Ensures all products and operational processes strictly comply with Indonesian pharmaceutical regulations and standards, upholding patient safety and product efficacy.

PT Mitsubishi Tanabe Pharma Indonesia plays a crucial role in bringing Mitsubishi Tanabe Pharma's global portfolio of medicines, particularly in therapeutic areas such as central nervous system disorders, immunology, and diabetes, to patients and healthcare providers in Indonesia.

PT Mitsubishi Tanabe Pharma in Indonesia manufactures or sells products primarily focused on specialty therapeutic areas. Their key product includes:

Radicava (Edaravone)

Therapeutic Area: Neurology, specifically for the treatment of Amyotrophic Lateral Sclerosis (ALS).